Use of a vegf receptor gener or gene product
OwnerArnd Buchwaldinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a VEGF receptor gene or receptor for the prevention or treatment of restenoses, ischaemia, arteriosclerosis and other cases of exuberant proliferation. The invention especially relates to the use thereof in therapy following balloon catheter treatment of the coronary vessels. The invention also relates to devices, such as stents, containing the VEGF receptor gene or gene product.
Claims14
The use of a VEGF receptor gene or gene product for producing a preparation for preventing and treating conditions and diseases, in particular arteriosclerosis and ischemia, which are accompanied by overshooting neointimal proliferation, for promoting neovascularization and for supportive therapy in connection with shunts, for the local treatment of areas of damage to the blood vessel endothelium, in particular before, during or after angioplasty, and for restenosis prophylaxis.
The use of a VEGF receptor gene or gene product for preventing and treating conditions and diseases, in particular arteriosclerosis and ischemia, which are accompanied by overshooting neointimal proliferation, for promoting neovascularization and for supportive therapy in connection with shunts, for local treatment of areas of damage to the blood vessel endothelium, in particular before, during or after angioplasty, and for restenosis prophylaxis.
A device, in particular stent or catheter, for use within blood vessels, comprising an effective quantity of a VEGF receptor gene or a VEGF receptor, or functional moieties thereof having the same biological effect.
Dependencies are inferred from the claim text.